Pharmerit rebrands to OPEN Health
May 20, 2021 |
OPEN Health is moving to one brand to create a world-class integrated services model
Pharmerit, a global leader in Health Economics and Outcomes Research (HEOR) and Market Access, has undergone an extensive rebranding to fully integrate with OPEN Health. Since its inception in 2011, OPEN Health has expanded its expertise and global reach through mergers and organic growth to be at the forefront of the healthcare industry. It has brought together global experts from HEOR, Market Access, and medical communications, with digital at the heart of its services. OPEN Health provides unrivalled global healthcare specialist expertise to apply innovative approaches in research and communications with the purpose of improving patient outcomes and wellbeing.
“We are one of the few global agencies that can serve clients across the full product lifecycle,” commented Rob Barker, CEO of OPEN Health. “We are proud to partner with 38 of the top 40 biopharmaceutical and medical device companies, serving clients from Medical Affairs, HEOR, Market Access, and Commercial teams.”
As of April 2021, OPEN Health has moved to one brand to create a world-class integrated services model. Together, we are a global team of 750+ experts across the United States, Europe, United Kingdom, and Asia.
“I am excited to say that we have retained the very best of Pharmerit, which has supported so many clients for over 20 years. We are now uniting equivalent life science research and communications talents from around the world under the OPEN Health brand, which has a strong heritage. We will continue on our journey to deliver on our evidence and access promise with a new, dynamic, and fully integrated team of experts,” added Jeff Anderson, CEO of OPEN Health Evidence & Access.
Speaking of Pharmerit’s clients, the former co-founder of Pharmerit and current Chair of OPEN Health Evidence & Access, Marc Botteman, commented, “I am proud to say that our clients will find a vastly broadened set of capabilities under the OPEN Health brand, including the expansion of value and HEOR communication and writing, the addition of patient engagement capabilities to our patient-centered outcomes expertise, the inclusion of primary data collection capabilities, and extensive access to UK and European databases. This will allow us to combine our novel data analytics and machine learning expertise with deep commercial market access expertise across Europe.”
Over the past 12 months, OPEN Health has cemented its status as a leader in HEOR and medical communications. It has experienced 20% YTY growth, tallying 1400 customers in 90+ countries. This growth reflects the increasing need for HEOR to inform healthcare decisions and to engage with the healthcare community in innovative and personalized ways.
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
Jeff Anderson joins OPEN Health as European Lead for OPEN VIE and Pharmerit
OPEN Health, the family of expert practices working in partnership to drive positive change in healthcare communications and market access, has appointed Jeff Anderson as European Lead for the combined...
OPEN Health Webinar – Succeeding with Star Wars Medicine
Summary of their recently published white paper on gene therapy followed by a Q&A session on 12th June 2020. Book now!
Yurie Oates, Account Director, OPEN Health gives us some Top tips from 5 years of account management on #MedCommsDay
WHAT IS ACCOUNT MANAGEMENT?Account/project managers support the day-to-day running of their account: they are the glue in a team who make sure projects are completed on brief, on time and...
A day in the life of an Associate Publications Director
Eleanor Raynsford, Associate Publications Director, OPEN Health gives us an insight into a day in the life of her role.
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time.
OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2
OPEN Health | European Congress on Rare Diseases (ECRD) 2020 in 60 seconds
Gavin Jones, Director or Rare Disease, attends the congress to better understand the viewpoints of patient groups, health systems and payers
OPEN Health attend day 2 of the ECRD2020 congress
Gavin Jones is looking forward to sessions on innovation in advanced therapies and working towards equitable access.
OPEN Health continued support for My Name’5 Doddie
Charity fundraising for Motor Neuron Disease